If it works, it could show that major international health projects, saving hundreds of thousands of lives, can be funded ...

LONDON, May 12 (Reuters) - Swiss drugmaker Novartis (NOVN.S), opens new tab will keep making medicines for malaria and leprosy, even if it does not get orders as normal amid the global health ...

Africa still bears the brunt of the global malaria burden—with 94 per cent of cases occurring on the continent. According to the World Health Organisation’s 2024 World Malaria Report ...

On Malaria burden in the state, the commissioner said, “Going by the last data, it is about 20.8 per cent, but with all the interventions that we have put in place, at the next survey, it would ...

LONDON (Reuters) -Swiss drugmaker Novartis will keep making medicines for malaria and leprosy, even if it does not get orders as normal amid the global health funding crunch, its president of ...

The Mpumalanga Department of Health has recorded a 59% reduction in malaria cases in the 2024/25 fiscal year. In the current year 1 066 cases were recorded, a significant drop compared with 2 578 ...

The concept of 'standby emergency treatment' (SBET) describes the strategy where travelers carry an emergency malaria treatment for self-administration when no medical attention is available or ...

Novartis and the non-profit Medicines for Malaria Venture (MMV) have advanced a novel drug combination for malaria into a phase 3 programme, raising hopes of a regimen that could be used to treat ...

The clinical spectrum of intestinal E. histolytica infection ranges from an asymptomatic carrier state to severe invasive disease. Asymptomatic cyst carriage occurs with E. histolytica as well as ...

Antimicrobial resistance is the ability of microorganisms such as bacteria, fungi or protozoans to grow despite exposure to antimicrobial substances designed to inhibit their growth. Microbes can ...

Antibodies are a crucial part of the body's specific defense against infectious diseases and have considerable potential as therapeutic and prophylactic agents in humans and animals. The ...